1 of 1
Story summary
- Health Secretary Robert F. Kennedy Jr. announced a U.S. program to reduce SSRI antidepressant use, now underway.
- The plan reimburses physicians for tapering patients, shares prescribing data, and funds training.
- HHS officials briefly examined SSRI restrictions but later denied any ban discussions.
- The American Psychiatric Association says SSRIs are first-line treatments.
- Experts note the FDA cannot ban approved drugs without new safety evidence, citing the Tavneos request Amgen refused.
